// App-Quantinova.ai

4939 : Evaluating a novel biomarkers set for postoperative outcome in patients with gastrointestinal cancer

Researchers

Presenter

  • Kunizaki Masaki

Principal Investigators

  • Shigekazu Hidaka

  • Tetsurou Tominaga

  • Yoichi Furukawa

  • Takeshi Nagayasu

Medical Centers

  • Univ. of Nagasaki, Nagasaki, Japan

  • Univ. of Tokyo, Tokyo, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

  • Solid malignancies

Biomarkers

  • p53

  • Carbohydrate antigen 19-9

  • Carcinoembryonic antigen

  • Glasgow prognostic score

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved